SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-027086
Filing Date
2022-05-16
Accepted
2022-05-16 16:05:45
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_moonlake.htm   iXBRL 10-Q 405477
2 CERTIFICATION f10q0322ex31-1_moonlake.htm EX-31.1 12564
3 CERTIFICATION f10q0322ex31-2_moonlake.htm EX-31.2 11960
4 CERTIFICATION f10q0322ex32-1_moonlake.htm EX-32.1 5011
5 CERTIFICATION f10q0322ex32-2_moonlake.htm EX-32.2 4929
  Complete submission text file 0001213900-22-027086.txt   2632637

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE hlxa-20220331.xsd EX-101.SCH 34540
7 XBRL CALCULATION FILE hlxa-20220331_cal.xml EX-101.CAL 17764
8 XBRL DEFINITION FILE hlxa-20220331_def.xml EX-101.DEF 156903
9 XBRL LABEL FILE hlxa-20220331_lab.xml EX-101.LAB 272790
10 XBRL PRESENTATION FILE hlxa-20220331_pre.xml EX-101.PRE 160098
41 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_moonlake_htm.xml XML 224593
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 22928786
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences